Parkinson

A version of exenatide failed a phase II trial, but hinted at benefits in patients under 60.

Columnist Jamie Askari shares her approach to being a family caregiver for a husband who was diagnosed with early-onset Parkinson's at 38.

For this purpose, it binds to certain protein chains that serve as markers for cellular waste removal, thus promoting the degradation of the harmful aggregates.

The Phase 3 HARMONY trial found Nuplazidoutperformed a placebo at managing psychosis in Parkinson's disease dementia patients.

A recent systematic practice review outlined pragmatic recommendations to enhance palliative care for patients with Parkinson disease and their caregivers, ...

The McNeill Dysphagia Therapy Progr is being studied by Giselle Carnaby at UTHSA's Swallowing and Upper Aerodigestive Research Laboratory.

Neurodegenerative diseases, such as Parkinson's or Alzheimer's, are associated with the deposition of protein aggregates in the brain.

Gary has Parkinson's disease, which he blames on exposure to the herbicide paraquat, and is part of a lawsuit against its manufacturer seeking damages trying to ...

"We are excited to discuss our joint efforts with Daewoong and NurrOn at the Sachs Neuroscience Innovation Forum, a premier event in the neuroscience community.

New findings about key pathological protein in Parkinson's disease open paths to novel therapies. Findings focus on alpha-synuclein and its role in killing ...

Randy Schekman, a cell biologist at the University of California at Berkeley, won the 2013 Nobel Prize in medicine for his insights into how yeast cells ...

Short-term daily use of cannabis did not significantly improve motor and nonmotor symptoms of Parkinson disease, relative to placebo.

Researchers from Johns Hopkins University School of Medicine have revealed new findings about a key pathological protein associated with Parkinson's disease ...